About DxGen
DxGen is a company based in Gunpo (South Korea) founded in 2016. DxGen offers products and services including Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE. DxGen operates in a competitive market with competitors including SD Biosensor, Access Bio, Lumos Diagnostics, 1Drop Diagnostics and Fluxergy, among others.
- Headquarter Gunpo, South Korea
- SectorsHealthcare
- Email••••••••
- Website dxgenco.com
- Legal Name (주)딕스젠 Dxgen Corp
Products & Services of DxGen
DxGen offers a comprehensive portfolio of products and services, including Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE.
Reliable system for diabetes and infectious disease testing.
Determines Glycated Hemoglobin levels in human blood.
Measures C-reactive protein in blood for diagnostics.
System for HbA1c and other biomarker testing.
Provides tools for biomarker analysis and diagnostics.
Competitors of DxGen
DxGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, Access Bio, Lumos Diagnostics, 1Drop Diagnostics and Fluxergy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| accessbio.net | 2001 | Somerset, United States | $22M | 52 | In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases. | |
| lumosdiagnostics.com | 2017 | Carlsbad, United States | $40M | – | Diversified diagnostic assays and readers are developed for point-of-care use. | |
| 1dropdx.com | 2012 | Neuchatel, Switzerland | $7.75M | – | Finger-prick point-of-care diagnostics are provided for biomarker testing. | |
| fluxergy.com | 2011 | Irvine, United States | – | 74 | Provides diagnostic devices and software for clinical and veterinary point-of-care testing. | |
| diabetomics.com | 2008 | Hillsboro, United States | $11M | 35 | Point-of-care tests for diabetes and women's health risks are developed. | |
| moduleinnovations.com | 2014 | Pune, India | $799,890 | – | Diagnostics strip for bacterial detection | |
| ptsdiagnostics.com | 1992 | Indianapolis, United States | – | 211 | Point-of-care diagnostic instruments are developed for disease testing. | |
| novabiomedical.com | 1976 | Waltham, United States | – | – | Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally. |
Detailed competitors of DxGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dxgen
Complete news archive for DxGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to DxGen
10 companies that operate in the same segment as DxGen (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DxGen
DxGen was founded in 2016.
DxGen is headquartered in Gunpo, South Korea. It is registered at Gunpo, Gyeonggi, South Korea.
DxGen was founded in 2016 and operates in the healthcare diagnostics sector. Point-of-care analyzers and test kits are supplied for diabetes management, covering stages from initial assessment to post-diagnosis treatment. Measurements include HbA1c, glycated albumin, CRP, hemoglobin, micro-albumin, and tuberculosis markers. Multi-marker diagnostic devices for diabetes and tuberculosis patients are under development.
DxGen's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
DxGen offers Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE.
DxGen operates through (주)딕스ì Dxgen Corp.